Stock Information
DiaMedica Therapeutics Inc (DMAC)
Ticker Symbol: DMAC
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $337.46 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -0.6995
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -77.62%
Latest News
-
DiaMedica Therapeutics Inc. (DMAC) Q1 2026 Earnings Call Transcript
Thu, May 7, 2026 3:11 PM
-
Transcript : DiaMedica Therapeutics Inc., Q1 2026 Earnings Call, May 07, 2026
Thu, May 7, 2026 2:51 PM
-
DiaMedica Therapeutics (NASDAQ:DMAC) Posts Wider Q1 Loss but Clinical Catalysts Fuel Stock Resilience
Wed, May 6, 2026 11:47 PM
-
Earnings Scheduled For May 6, 2026
Wed, May 6, 2026 5:03 PM
-
DiaMedica Therapeutics Q1 EPS $(0.19), Inline
Wed, May 6, 2026 4:32 PM
-
DiaMedica Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights
Wed, May 6, 2026 4:31 PM
Key Financials
Financial data not available
